The Manila Times

Intravacc Highlights Four Integrated Vaccine Development Platforms for CDMO Partners

Proven bacterial, viral, conjugate, and E.coli expression platforms support partners from discovery and process development to GMP readiness and clinical manufacturing ...

Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010

VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news ...

Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development

Qualified Vero Master Cell Bank and Working Cell Bank, originating from WHO banks, are available for purchase, licensing, and use in ...

WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance facility located at the Shanghai Fengxian site ...

Lotte Biologics, Asimov unveil next-gen CDO model that cuts DNA-to-GMP timeline to 8.5 months

Lotte Biologics has teamed up with US biotech firm Asimov to unveil a next-generation contract development organization (CDO) ...

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

(NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; ...

Intravacc B.V.: Intravacc Makes Qualified Vero Cell Banks Available to Accelerate Viral Vaccine Development

WHO-origin Master and Working Cell Banks provide vaccine developers with a ready-to-use Vero cell substrate for licensing, purchase, and integrated CDMO programsQualified Vero Master Cell Bank and Wor ...

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

VANCOUVER, BC / ACCESS Newswire / June 23, 2026 / Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a ...
Pharmabiz

Shilpa Biologicals launches PartnerPower, a proprietary platform for real-time visibility on process development

Shilpa Biologicals launches PartnerPower, a proprietary platform for real-time visibility on process development: Our Bureau, Mumbai Tuesday, June 23, 2026, 12:45 Hrs [IST] Shilpa ...
FierceBiotech

Beyond Rigid Platforms: Adaptive Adenoviral Platform De-Risks Development to GMP

An adenoviral process that works for one construct can fail with the next. A harvest step optimized in development can erode yield at scale, and an early analytical method can stall a program at ...
The Manila Times

Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003

Publication Highlights Novel Intravenous Everolimus Formulation and Demonstrates Broad Potential of Deciparticle™ Technology for Hydrophobic Therapeutics ...
technologynetworks

Next-Generation Process Analytics and Industrial QC Testing

Process analytical technology in biomanufacturing has undergone a fundamental transformation over the past two decades, moving quality control from the analytical laboratory to the manufacturing floor ...